Clinical pharmacology in neonates and young infants: The benefit of a population-tailored approach

John Van Den Anker, Karel Allegaert*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)5-8
Number of pages4
JournalExpert Review of Clinical Pharmacology
Issue number1
Publication statusPublished - 2012

Bibliographical note

Funding Information:
J van den Anker is supported in part by NIH grants (R01HD060543, K24DA027992, R01HD048689 and U54HD071601) and FP7 grants TINN (223614), TINN2 (260908) and NEUROSIS (223060). K Allegaert is supported by the Fund for Scientific Research, Flanders (Belgium) (FWO Vlaanderen) by a Fundamental Clinical Investigatorship (1800209N). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Cite this